Cite
Au-Yeung SK, Griffiths J, Roberts S, et al. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health. 2021;doi: 10.1136/ebmental-2021-300282.
Au-Yeung, S. K., Griffiths, J., Roberts, S., Edwards, C., Yu, L. M., Bogacz, R., Rendell, J., Attenburrow, M. J., Watson, S., Chan, F., Cipriani, A., Cleare, A., Harmer, C. J., Kessler, D., Evans, J., Lewis, G., Singh, I., Simon, J., Harrison, P. J., Cowen, P., Shanyinde, M., Geddes, J., & Browning, M. (2021). PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evidence-based mental health, . https://doi.org/10.1136/ebmental-2021-300282
Au-Yeung, Sheena Kristine, et al. "PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression." Evidence-based mental health vol. (2021). doi: https://doi.org/10.1136/ebmental-2021-300282
Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, Rendell J, Attenburrow MJ, Watson S, Chan F, Cipriani A, Cleare A, Harmer CJ, Kessler D, Evans J, Lewis G, Singh I, Simon J, Harrison PJ, Cowen P, Shanyinde M, Geddes J, Browning M. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health. 2021 Nov 22; doi: 10.1136/ebmental-2021-300282. Epub 2021 Nov 22. PMID: 34810175.
Copy
Download .nbib